USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$57.95M
Market Cap
-
P/E Ratio
-3.78
EPS
$7.10
52 Week High
$2.27
52 Week Low
CONSUMER DEFENSIVE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $272K |
Total Revenue | $342K |
Cost Of Revenue | $70K |
Costof Goods And Services Sold | $70K |
Operating Income | -$33M |
Selling General And Administrative | $13M |
Research And Development | $20M |
Operating Expenses | $33M |
Investment Income Net | - |
Net Interest Income | -$4M |
Interest Income | $865K |
Interest Expense | $4.1M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.6M |
Income Before Tax | -$39M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$39M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$34M |
Net Income | -$39M |
Field | Value (USD) |
---|---|
Total Assets | $27M |
Total Current Assets | $16M |
Cash And Cash Equivalents At Carrying Value | $12M |
Cash And Short Term Investments | $12M |
Inventory | $68K |
Current Net Receivables | $391K |
Total Non Current Assets | $11M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $0 |
Other Current Assets | $3.5M |
Other Non Current Assets | - |
Total Liabilities | $36M |
Total Current Liabilities | $10M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.3M |
Total Non Current Liabilities | $26M |
Capital Lease Obligations | $5.1M |
Long Term Debt | $15M |
Current Long Term Debt | $359K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $21M |
Other Current Liabilities | $5.1M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$8.9M |
Treasury Stock | - |
Retained Earnings | -$282M |
Common Stock | $1K |
Common Stock Shares Outstanding | $7M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$21M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.6M |
Capital Expenditures | $15K |
Change In Receivables | - |
Change In Inventory | -$31K |
Profit Loss | - |
Cashflow From Investment | $6.3M |
Cashflow From Financing | -$1.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$39M |
Field | Value (USD) |
---|---|
Gross Profit | $272K |
Total Revenue | $342K |
Cost Of Revenue | $70K |
Costof Goods And Services Sold | $70K |
Operating Income | -$33M |
Selling General And Administrative | $13M |
Research And Development | $20M |
Operating Expenses | $33M |
Investment Income Net | - |
Net Interest Income | -$4M |
Interest Income | $865K |
Interest Expense | $4.1M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.6M |
Income Before Tax | -$39M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$39M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$34M |
Net Income | -$39M |
Sector: CONSUMER DEFENSIVE
Industry: PACKAGED FOODS
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.